Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Lung Neoplasms and SHE[original query] |
|---|
| Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation. Nature clinical practice. Oncology 2006 1 3 (1): 50-7; quiz 1 p following 57. Choong Nicholas W, Dietrich Sascha, Seiwert Tanguy Y, Tretiakova Maria S, Nallasura Vidya, Davies Gareth C, Lipkowitz Stanley, Husain Aliya N, Salgia Ravi, Ma Patrick |
| Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Aug 29 (24): 3316-21. Zhou Qing, Zhang Xu-Chao, Chen Zhi-Hong, Yin Xiao-Lu, Yang Jin-Ji, Xu Chong-Rui, Yan Hong-Hong, Chen Hua-Jun, Su Jian, Zhong Wen-Zhao, Yang Xue-Ning, An She-Juan, Wang Bin-Chao, Huang Yi-Sheng, Wang Zhen, Wu Yi-Lo |
| Clinical Efficacy of Afatinib Treatment for a Patient with Leptomeningeal Carcinomatosis. Chemotherapy 2016 12 62 (3): 147-150. Kawaguchi Yo, Hanaoka Jun, Hayashi Hideki, Mizusaki Naoki, Iihara Hirotoshi, Itoh Yoshinori, Sugiyama Tadas |
| Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report. Journal of Korean medical science 2017 12 33 (1): e7. Park Cheol Kyu, Hur Jae Young, Choi Chang Min, Kim Tae Ok, Cho Hyun Ju, Shin Hong Joon, Lim Jung Hwan, Choi Yoo Duk, Kim Young Chul, Oh In J |
| SMARCA4 germline gene mutation in a patient with epithelial ovarian: A case report. Gynecologic oncology reports 2017 12 22 45-47. Muppala Reshma, Donenberg Talia, Huang Marilyn S, Schlumbrecht Matthew |
| ROS1-ADGRG6: a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib. BMC cancer 2019 Aug 19 (1): 769. Xu Shuguang, Wang Wenxian, Xu Chunwei, Li Xingliang, Ye Junhui, Zhu Youcai, Ge Ti |
| Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to Osimertinib. Internal medicine (Tokyo, Japan) 2019 2 58 (11): 1625-1627. Makimoto Go, Ohashi Kadoaki, Senoo Satoru, Hotta Katsuyuki, Maeda Yoshinobu, Kiura Katsuyu |
| The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Frontiers in pharmacology 2020 11 1029. Zou Ting, Liu Jun-Yan, She Li, Yin Ji-Ye, Li Xi, Li Xiang-Ping, Zhou Hong-Hao, Chen Juan, Liu Zhao-Qi |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| Coexistence of atypical adenomatous hyperplasia, minimally invasive adenocarcinoma and invasive adenocarcinoma: Gene mutation analysis. Thoracic cancer 2021 1 12 (5): 693-698. Song Junya, Xu Yinghui, Yang Zhiguang, Liu Yunpeng, Zhang Peng, Wang Xu, Sun Chao, Guo Ye, Qiu Shi, Shao Guoguang, Ma Kew |
| Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant ( L833V / H835L ) lung adenocarcinoma patient : a case report. Anti-cancer drugs 2023 5 . Zhilin Luo, Chengwen Luo, Runquan Zhou, Yajie Xiao, Tianhu Wa |
| Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report. International journal of molecular sciences 2023 1 24 (1): . Chen Zi-Wei, Lin Gigin, Shih Hsuan-Jen, Wu Chiao- |
| Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report. Oncotarget 2024 1 15 27-30. Shreya Bhatia, Manuel G Cortez, Spencer Lessans, Wade T Ia |
- Page last reviewed:Feb 1, 2024
- Content source: